Alkylating agents induce histone H3K18 hyperacetylation and potentiate HDAC inhibitor-mediated global histone acetylation and cytotoxicity in mantle cell lymphoma-Reference-Cited by-同舟云学术

Alkylating agents induce histone H3K18 hyperacetylation and potentiate HDAC inhibitor-mediated global histone acetylation and cytotoxicity in mantle cell lymphoma

Published:2013-12 Issue:12 Volume:3 Page:e169-e169
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Hiraoka N,Kikuchi J,Koyama D,Wada T,Mori S,Nakamura Y,Furukawa Y

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201366.pdf

Reference15 articles.

1. Horwitz GA, Zhang K, McBrian MA, Grunstein M, Kurdistani SK, Berk AJ . Adenovirus small e1a alters global patterns of histone modification. Science 2008; 321: 1084–1085.

2. Eskandarian HA, Impens F, Nahori M-A, Soubigou G, Coppée J-Y, Cossart P et al. A role for SIRT2-dependent histone H3K18 deacetylation in bacterial infection. Science 2013; 341: 1238858.

3. Barber MF, Michishita-Kioi E, Xi Y, Tasselli L, Kioi M, Moqtaderi Z et al. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 2012; 487: 114–118.

4. Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005; 435: 1262–1266.

5. Manuyakorn A, Paulus R, Farrell J, Dawson NA, Tze S, Cheung-Lau G et al. Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. J Clin Oncol 2010; 28: 1358–1365.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An in silico drug repurposing approach to identify HDAC1 inhibitors against glioblastoma;Journal of Biomolecular Structure and Dynamics;2024-04-30

2. Transcription suppression is mediated by the HDAC1–Sin3 complex in Xenopus nucleoplasmic extract;Journal of Biological Chemistry;2022-11

3. Serum IgG and lymphocyte counts are useful for the early detection of infection in patients receiving bendamustine-rituximab therapy;Journal of Clinical and Experimental Hematopathology;2022

4. Autophagic degradation of NOXA underlies stromal cell-mediated resistance to proteasome inhibitors in mantle cell lymphoma;Leukemia Research;2021-12

5. Bone marrow stromal cell-mediated degradation of CD20 leads to primary rituximab resistance in mantle cell lymphoma;Leukemia;2020-09-14